Browsing by Author "405690b4-8c1c-4406-b0d7-c5adc60a5d82"

Now showing items 1-6 of 6

    • 14th World Immune Regulation Meeting - Q&A with the EJI-EFIS Travel grant winners 
      McManus, Caitlin; Davies, James; Maggi, Jaxaira; Richter, Jens; Goretzki, Alexandra; Aarebrot, Anders K.; Monteiro, Andreia; Delemarre, Tim; Cisarova, Radka; Sarajlic, Muamera (Wiley, 2020)
    • Dexamethasone and monophosphoryl lipid a induce a distinctive profile on monocyte-derived dendritic cells ... 
      García González, Paulina; Schinnerling, Katina; Sepúlveda Gutierrez, Alejandro; Maggi, Jaxaira; Mehdi, Ahmed M.; Nel, Hendrik J.; Pesce Reyes, Bárbara; Larrondo Lillo, Milton; Aravena, Octavio; Molina Sampayo, María Carmen; Catalán Martina, Diego; Thomas, Ranjeny; Verdugo Salgado, Ricardo; Aguillón Gutiérrez, Juan Carlos (Frontiers Media SA, 2017)
      There is growing interest in the use of tolerogenic dendritic cells (tolDCs) as a potential target for immunotherapy. However, the molecular bases that drive the differentiation of monocyte-derived DCs (moDCs) toward a ...
    • Dexamethasone and Monophosphoryl Lipid A-Modulated Dendritic Cells Promote Antigen-Specific Tolerogenic ... 
      Maggi, Jaxaira; Schinnerling, Katina; Pesce Reyes, Bárbara; Hilkens, Catharien M.; Catalán Martina, Diego; Aguillón Gutiérrez, Juan Carlos (Frontiers Media, 2016)
      Tolerogenic dendritic cells (DCs) are a promising tool to control T cell-mediated autoimmunity. Here, we evaluate the ability of dexamethasone-modulated and monophosphoryl lipid A (MPLA)-activated DCs [MPLA-tolerogenic DCs ...
    • Regulation of tolerogenic features on dexamethasone-modulated MPLA-activated dendritic cells by Myc 
      García González, Paulina; Maggi, Jaxaira; Schinnerling, Katina; Sepúlveda Gutiérrez, Alejandro; Soto, Lilian; Neira, Oscar; Mehdi, Ahmed M.; Nel, Hendrik J.; Pesce, Bárbara; Aravena, Octavio; Molina, María Carmen; Catalán, Diego; Thomas, Ranjeny; Verdugo Salgado, Ricardo (Frontiers Media S.A., 2019)
      Copyright © 2019 García-González, Maggi, Schinnerling, Sepúlveda-Gutiérrez, Soto, Neira, Mehdi, Nel, Pesce, Aravena, Molina, Catalán, Thomas, Verdugo and Aguillón.The potential of tolerogenic dendritic cells (tolDCs) to ...
    • Therapeutic potential of hyporesponsive CD4+ T cells in autoimmunity 
      Maggi, Jaxaira; Schafer, Carolina; Ubilla Olguín, Gabriela; Catalán Martina, Diego; Schinnerling, Katina; Aguillón Gutiérrez, Juan Carlos (Frontiers Media S.A., 2015)
      © 2015 Maggi, Schafer, Ubilla-Olguín, Catalán, Schinnerling and Aguillón. The interaction between dendritic cells (DCs) and T cells is crucial on immunity or tolerance induction. In an immature or semi-mature state, DCs ...
    • Treatment with dexamethasone and monophosphoryl lipid a removes disease-associated transcriptional signatures ... 
      García González, Paulina; Schinnerling, Katina; Sepúlveda Gutiérrez, Alejandro; Maggi, Jaxaira; Hoyos, Lorena; Morales, Rodrigo; Mehdi, Ahmed; Nel, Hendrik; Soto Sáez, Lilian; Pesce Reyes, Bárbara; Molina Sampayo, María Carmen; Cuchacovich Turteltaub, Miguel; Larrondo Lillo, Milton; Neira, Oscar; Catalán Martina, Diego; Hilkens, Catharien M.; Thomas, Ranjeny; Verdugo Salgado, Ricardo; Aguillón Gutiérrez, Juan Carlos (Frontiers Media, 2016-10-25)
      Tolerogenic dendritic cells (TolDCs) are promising tools for therapy of autoimmune diseases, such as rheumatoid arthritis (RA). Here, we characterize monocyte-derived TolDCs from RA patients modulated with dexamethasone ...